“The Use of Double Test Biomarkers to Predict Fetal Nuchal Translucency Thickness in the Diagnosis of Trisomy 21: A Compromise between Sensitivity and Specificity”, Cent Asian J Med Sci, vol. 4, no. 3, pp. 230–237, Sep. 2018, doi: 10.24079/cajms.2018.09.009.